Dara Gantly examines some of the fine print in the first full-year business plan from the Medical Council.
Editorial
Harney’s magic bullet
Dara Gantly believes Harney’s prevention may well prove better than her cure.
Cabinet Fever epidemic
Dara Gantly brings you an update on the latest Cabinet Fever outbreak.
Of primary importance
Dara Gantly examines whether increased prescriptions are behind a rare good news story about the health service.
An epiphany, of sorts
Dara Gantly follows the star in the East to record trolley figures and health insurance hikes
Clinging for dear life to our health gains
Dara Gantly writes that while ‘out with the old’ may well be the clarion call for the health service in the year to come, some things are worth holding on to in 2011 We have said goodbye to 2010 and the Noughties since our last editorial, and many would bid good riddance to both.
All I want for Christmas
Dara Gantly gets on his bike for the perfect Christmas present, with the help of some festive medical research Growing up, I always knew what I ideally wanted for Christmas.
Obsessive Economic Compulsive Disorder
Dara Gantly examines the latest thinking on healthcare efficiency from the Organisation for Economic Co-operation and Development (OECD) and where Ireland fits in with the analysis Given the week that’s in it, you will forgive me for sticking to an economic theme.
The audacity of hope
Retaining hope in the face of such difficulty and uncertainty is not an easy thing, says Dara Gantly At the exact time that the Taoiseach was unveiling the Government’s four-year National Recovery Plan last Wednesday, Ireland’s health service luminaries were meeting in the Round Room of the Mansion House in Dublin for the HSE’s annual Achievement Awards (see page 4
Tough medicine for tougher times
With a €1 billion black hole in the health finances, the Government has been given a diagnosis by doctors and told to take its medicines The price of medicines here in Ireland hit the headlines and the national airwaves again last week, as it emerged that the wholesale price of hydrocortisone tablets had sky-rocketed 2,200 per cent, from just 96